304 related articles for article (PubMed ID: 18061638)
1. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
[TBL] [Abstract][Full Text] [Related]
2. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
Katsuki Y; Sasagawa S; Takano Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
Drugs Exp Clin Res; 1997; 23(2):45-62. PubMed ID: 9309380
[TBL] [Abstract][Full Text] [Related]
3. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
Katsuki Y; Shibutani Y; Aoki D; Nozawa S
Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
[TBL] [Abstract][Full Text] [Related]
4. [The behavior of cytoplasmic progesterone receptors in the cycling endometrium and the effect of hormonal contraceptives].
Carol W; Jäger R; Martin P; Möller U
Zentralbl Gynakol; 1989; 111(12):793-9. PubMed ID: 2763749
[TBL] [Abstract][Full Text] [Related]
5. [The endocrinologic profile of metabolites of the progestin dienogest].
Oettel M; Kaufmann G; Kurischko A
Pharmazie; 1993 Jul; 48(7):541-5. PubMed ID: 8415850
[TBL] [Abstract][Full Text] [Related]
6. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression.
Shimizu Y; Takeuchi T; Mita S; Mizuguchi K; Kiyono T; Inoue M; Kyo S
Mol Hum Reprod; 2009 Oct; 15(10):693-701. PubMed ID: 19502247
[TBL] [Abstract][Full Text] [Related]
7. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of the progestin dienogest (STS 557) in rabbits.
Hillesheim HG; Ritter P; Valentin U; Hobe G
Exp Clin Endocrinol; 1989 Sep; 94(1-2):194-202. PubMed ID: 2599018
[TBL] [Abstract][Full Text] [Related]
9. Valproate is an anti-androgen and anti-progestin.
Death AK; McGrath KC; Handelsman DJ
Steroids; 2005 Dec; 70(14):946-53. PubMed ID: 16165177
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation.
García-Becerra R; Ordaz-Rosado D; Noé G; Chávez B; Cooney AJ; Larrea F
Reproduction; 2012 Feb; 143(2):211-9. PubMed ID: 22065861
[TBL] [Abstract][Full Text] [Related]
11. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
[TBL] [Abstract][Full Text] [Related]
12. Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays.
Schreurs RH; Sonneveld E; Jansen JH; Seinen W; van der Burg B
Toxicol Sci; 2005 Feb; 83(2):264-72. PubMed ID: 15537743
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
[TBL] [Abstract][Full Text] [Related]
14. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Grandi G; Mueller MD; Bersinger NA; Facchinetti F; McKinnon BD
Gynecol Endocrinol; 2017 Sep; 33(9):712-715. PubMed ID: 28412861
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of estradiol valerate/dienogest.
Teichmann A
Climacteric; 2003 Aug; 6 Suppl 2():17-23. PubMed ID: 14669840
[TBL] [Abstract][Full Text] [Related]
17. Novel progesterone receptor modulators with gene selective and context-dependent partial agonism.
Berrodin TJ; Jelinsky SA; Graciani N; Butera JA; Zhang Z; Nagpal S; Winneker RC; Yudt MR
Biochem Pharmacol; 2009 Jan; 77(2):204-15. PubMed ID: 19013437
[TBL] [Abstract][Full Text] [Related]
18. Receptor profiling and endocrine interactions of tibolone.
de Gooyer ME; Deckers GH; Schoonen WG; Verheul HA; Kloosterboer HJ
Steroids; 2003 Jan; 68(1):21-30. PubMed ID: 12475720
[TBL] [Abstract][Full Text] [Related]
19. Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey.
van Diepen HA; Lam TW; Kuil CW
Contraception; 2011 Aug; 84(2):199-204. PubMed ID: 21757063
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
